Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34709 | 107 | 35.6 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
373 | 3 | ENDOGENOUS RETROVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 32972 |
2228 | 2 | C MYB//B MYB//SRC | 4790 |
34709 | 1 | CDCP1//CUB DOMAIN CONTAINING PROTEIN 1//TRASK | 107 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CDCP1 | authKW | 6290239 | 21% | 96% | 23 |
2 | CUB DOMAIN CONTAINING PROTEIN 1 | authKW | 1141518 | 4% | 100% | 4 |
3 | TRASK | authKW | 856139 | 3% | 100% | 3 |
4 | SUBTRACTIVE IMMUNIZATION | authKW | 548801 | 5% | 38% | 5 |
5 | 3 D PHENOTYPIC SCREENING | authKW | 285380 | 1% | 100% | 1 |
6 | BREAST ANAT PATHOL | address | 285380 | 1% | 100% | 1 |
7 | CD318 | authKW | 285380 | 1% | 100% | 1 |
8 | CDCP1 COPY NUMBER | authKW | 285380 | 1% | 100% | 1 |
9 | CDNA CHIP TECHNOLOGY | authKW | 285380 | 1% | 100% | 1 |
10 | GP140 CUB DOMAIN CONTAINING PROTEIN 1 | authKW | 285380 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1022 | 50% | 0% | 54 |
2 | Cell Biology | 560 | 37% | 0% | 40 |
3 | Biochemical Research Methods | 171 | 14% | 0% | 15 |
4 | Biochemistry & Molecular Biology | 164 | 35% | 0% | 37 |
5 | Genetics & Heredity | 88 | 13% | 0% | 14 |
6 | Immunology | 73 | 14% | 0% | 15 |
7 | Pathology | 33 | 6% | 0% | 6 |
8 | Hematology | 10 | 4% | 0% | 4 |
9 | Cell & Tissue Engineering | 9 | 1% | 0% | 1 |
10 | Biotechnology & Applied Microbiology | 6 | 5% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BREAST ANAT PATHOL | 285380 | 1% | 100% | 1 |
2 | LEIDEN BIOPARTNER | 285380 | 1% | 100% | 1 |
3 | MATER OVARIAN CANC ABORAT | 285380 | 1% | 100% | 1 |
4 | MICROMET CORP | 285380 | 1% | 100% | 1 |
5 | YONG LIN BIOMED ENGN | 285380 | 1% | 100% | 1 |
6 | METASTASIS INVAS SIGNALING | 268586 | 4% | 24% | 4 |
7 | DISCOVERY ONCOL PHARMACEUT EARLY DEV PRED | 142689 | 1% | 50% | 1 |
8 | EYETECH | 95125 | 1% | 33% | 1 |
9 | CHERYL BROWN OVARIAN CANC OUTCOMES UNIT | 67145 | 2% | 12% | 2 |
10 | UMR S972 | 57074 | 1% | 20% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOSCIENCE TRENDS | 2467 | 2% | 0% | 2 |
2 | ONCOGENE | 2274 | 11% | 0% | 12 |
3 | MOLECULAR CANCER RESEARCH | 1372 | 3% | 0% | 3 |
4 | HYBRIDOMA | 1219 | 3% | 0% | 3 |
5 | HYBRIDOMA AND HYBRIDOMICS | 1163 | 1% | 0% | 1 |
6 | JOURNAL OF IMMUNOLOGICAL METHODS | 1059 | 6% | 0% | 6 |
7 | JOURNAL OF BUON | 817 | 2% | 0% | 2 |
8 | CANCER SCIENCE | 725 | 3% | 0% | 3 |
9 | AMERICAN JOURNAL OF PATHOLOGY | 559 | 5% | 0% | 5 |
10 | IMMUNOLOGY AND CELL BIOLOGY | 495 | 2% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CDCP1 | 6290239 | 21% | 96% | 23 | Search CDCP1 | Search CDCP1 |
2 | CUB DOMAIN CONTAINING PROTEIN 1 | 1141518 | 4% | 100% | 4 | Search CUB+DOMAIN+CONTAINING+PROTEIN+1 | Search CUB+DOMAIN+CONTAINING+PROTEIN+1 |
3 | TRASK | 856139 | 3% | 100% | 3 | Search TRASK | Search TRASK |
4 | SUBTRACTIVE IMMUNIZATION | 548801 | 5% | 38% | 5 | Search SUBTRACTIVE+IMMUNIZATION | Search SUBTRACTIVE+IMMUNIZATION |
5 | 3 D PHENOTYPIC SCREENING | 285380 | 1% | 100% | 1 | Search 3+D+PHENOTYPIC+SCREENING | Search 3+D+PHENOTYPIC+SCREENING |
6 | CD318 | 285380 | 1% | 100% | 1 | Search CD318 | Search CD318 |
7 | CDCP1 COPY NUMBER | 285380 | 1% | 100% | 1 | Search CDCP1+COPY+NUMBER | Search CDCP1+COPY+NUMBER |
8 | CDNA CHIP TECHNOLOGY | 285380 | 1% | 100% | 1 | Search CDNA+CHIP+TECHNOLOGY | Search CDNA+CHIP+TECHNOLOGY |
9 | GP140 CUB DOMAIN CONTAINING PROTEIN 1 | 285380 | 1% | 100% | 1 | Search GP140+CUB+DOMAIN+CONTAINING+PROTEIN+1 | Search GP140+CUB+DOMAIN+CONTAINING+PROTEIN+1 |
10 | MULTI PARAMETRIC PROFILING | 285380 | 1% | 100% | 1 | Search MULTI+PARAMETRIC+PROFILING | Search MULTI+PARAMETRIC+PROFILING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WRIGHT, HJ , ARULMOLI, J , MOTAZEDI, M , NELSON, LJ , HEINEMANN, FS , FLANAGAN, LA , RAZORENOVA, OV , (2016) CDCP1 CLEAVAGE IS NECESSARY FOR HOMODIMERIZATION-INDUCED MIGRATION OF TRIPLE-NEGATIVE BREAST CANCER.ONCOGENE. VOL. 35. ISSUE 36. P. 4762 -4772 | 32 | 62% | 0 |
2 | YANG, LF , DUTTA, SM , TROYER, DA , LIN, JB , LANCE, RA , NYALWIDHE, JO , DRAKE, RR , SEMMES, OJ , (2015) DYSREGULATED EXPRESSION OF CELL SURFACE GLYCOPROTEIN CDCP1 IN PROSTATE CANCER.ONCOTARGET. VOL. 6. ISSUE 41. P. 43743 -43758 | 26 | 68% | 0 |
3 | HE, Y , WU, AC , HARRINGTON, BS , DAVIES, CM , WALLACE, SJ , ADAMS, MN , PALMER, JS , ROCHE, DK , HOLLIER, BG , WESTBROOK, TF , ET AL (2016) ELEVATED CDCP1 PREDICTS POOR PATIENT OUTCOME AND MEDIATES OVARIAN CLEAR CELL CARCINOMA BY PROMOTING TUMOR SPHEROID FORMATION, CELL MIGRATION AND CHEMORESISTANCE.ONCOGENE. VOL. 35. ISSUE 4. P. 468 -478 | 21 | 58% | 6 |
4 | CASAR, B , RIMANN, I , KATO, H , SHATTIL, SJ , QUIGLEY, JP , DERYUGINA, EI , (2014) IN VIVO CLEAVED CDCP1 PROMOTES EARLY TUMOR DISSEMINATION VIA COMPLEXING WITH ACTIVATED BETA 1 INTEGRIN AND INDUCTION OF FAK/PI3K/AKT MOTILITY SIGNALING.ONCOGENE. VOL. 33. ISSUE 2. P. 255-268 | 22 | 67% | 20 |
5 | UEKITA, T , SAKAI, R , (2011) ROLES OF CUB DOMAIN-CONTAINING PROTEIN 1 SIGNALING IN CANCER INVASION AND METASTASIS.CANCER SCIENCE. VOL. 102. ISSUE 11. P. 1943 -1948 | 24 | 63% | 11 |
6 | ADAMS, MN , HARRINGTON, BS , HE, Y , DAVIES, CM , WALLACE, SJ , CHETTY, NP , CRANDON, AJ , OLIVEIRA, NB , SHANNON, CM , COWARD, JI , ET AL (2015) EGF INHIBITS CONSTITUTIVE INTERNALIZATION AND PALMITOYLATION-DEPENDENT DEGRADATION OF MEMBRANE-SPANNING PROCANCER CDCP1 PROMOTING ITS AVAILABILITY ON THE CELL SURFACE.ONCOGENE. VOL. 34. ISSUE 11. P. 1375 -1383 | 22 | 61% | 3 |
7 | KOLLMORGEN, G , NIEDERFELLNER, G , LIFKE, A , SPOHN, GJ , RIEDER, N , HARRING, SV , BAUSS, F , BURTSCHER, H , LAMMERS, R , BOSSENMAIER, B , (2013) ANTIBODY MEDIATED CDCP1 DEGRADATION AS MODE OF ACTION FOR CANCER TARGETED THERAPY.MOLECULAR ONCOLOGY. VOL. 7. ISSUE 6. P. 1142-1151 | 16 | 80% | 7 |
8 | SEIDEL, J , KUNC, K , POSSINGER, K , JEHN, C , LUFTNER, D , (2011) EFFECT OF THE TYROSINE KINASE INHIBITOR LAPATINIB ON CUB-DOMAIN CONTAINING PROTEIN (CDCP1)-MEDIATED BREAST CANCER CELL SURVIVAL AND MIGRATION.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 414. ISSUE 1. P. 226-232 | 16 | 84% | 6 |
9 | TURDO, F , BIANCHI, F , GASPARINI, P , SANDRI, M , SASSO, M , DE CECCO, L , FORTE, L , CASALINI, P , AIELLO, P , SFONDRINI, L , ET AL (2016) CDCP1 IS A NOVEL MARKER OF THE MOST AGGRESSIVE HUMAN TRIPLE-NEGATIVE BREAST CANCERS.ONCOTARGET. VOL. 7. ISSUE 43. P. 69649 -69665 | 23 | 51% | 0 |
10 | GANDJI, LY , PROUST, R , LARUE, L , GESBERT, F , (2015) THE TYROSINE PHOSPHATASE SHP2 ASSOCIATES WITH CUB DOMAIN-CONTAINING PROTEIN-1 (CDCP1), REGULATING ITS EXPRESSION AT THE CELL SURFACE IN A PHOSPHORYLATION-DEPENDENT MANNER.PLOS ONE. VOL. 10. ISSUE 4. P. - | 22 | 51% | 2 |
Classes with closest relation at Level 1 |